Back

Effects of hybrid closed-loop systems and SGLT2i on myocardial deformation and vascular function in type 1 diabetics

29 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic pharmacotherapy for cardiovascular risk Antidiabetic Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Konstantinos Katogiannis

Attikon University Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Cardiovascular outcomes across GLP-1/GIP agonists in a large, diverse real-world cohort: the INCRETIN-CV study
Doctor C. Gurevitz (Petah Tikva, IL)
Abstract Slides
Presentation thumbnail
Comparative analysis of monthly weight-regain dynamics after discontinuation of semaglutide vs tirzepatide
Professor G. Fazio (Palermo, IT)
Abstract Slides
Presentation thumbnail
Semaglutide demonstrates favorable safety profile with 43% reduction in serious adverse events in adults with established ASCVD: a systematic review and meta-analysis of randomized controlled trials
Doctor V. Purewal (Scottsdale, US)
Abstract Slides
Presentation thumbnail
Tirzepatide confers superior cardiorenal protection compared to semaglutide in type 2 diabetes: insights from a large-scale propensity-matched real-world cohort
Doctor I. Zahan (Harefield, GB)
Abstract Slides
Presentation thumbnail
Prognostic outcomes of SGLT2 inhibitors versus metformin in patients with type 2 diabetes and acute myocardial infarction
Doctor H. Zhang (Tianjin, CN)
Abstract Slides

Access the full session

Session thumbnail
Cardiometabolic pharmacotherapy for cardiovascular risk

The Event

Event poster

ESC Congress 2026

29 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
3 September 2019
thumbnail
Congress Presentation
Endotypes of coronary microvascular dysfunction in patients with and without Diabetes Mellitus
25 August 2023
thumbnail
Congress Presentation
Diabetes mellitus in heart transplant recipients is associated with lower left ventricular strain and left atrial enlargement
1 September 2025
thumbnail
Congress Presentation
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources